1. Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondiirhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model
- Author
-
Ying Xu, Jia Chen, Zhu Xingquan, Qi-Dong Tan, Jing Lu, Qian-Ming Xu, and Nian-Zhang Zhang
- Subjects
DNA vaccine ,Protozoan Vaccines ,Mouse ,Protective immunity ,Protozoan Proteins ,Toxoplasma gondii ,Antibodies, Protozoan ,Injections, Intramuscular ,Microbiology ,DNA vaccination ,Mice ,Immune system ,Immunity ,medicine ,Vaccines, DNA ,Animals ,Humans ,Cell Proliferation ,Immunity, Cellular ,Rhoptry ,biology ,Vaccination ,Protein-Tyrosine Kinases ,biology.organism_classification ,medicine.disease ,Virology ,Toxoplasmosis ,Disease Models, Animal ,Infectious Diseases ,HEK293 Cells ,Toxoplasmosis, Animal ,TgROP38 ,Immunoglobulin G ,Interleukin-2 ,Female ,Toxoplasma ,Lymphoproliferative response ,Research Article - Abstract
Background Toxoplasma gondii is an obligate intracellular parasite which can infect almost all mammalian animals, leading to toxoplasmosis. T. gondii rhoptry protein 38 (TgROP38) is an active rhoptry protein kinase which is involved in the inhibitory effect on host cell transcription by down-regulating the MAPK signaling track. Methods TgROP38 gene was amplified and inserted into eukaryotic vector pVAX I and formed the DNA vaccine pVAX-ROP38. Mice in the experimental group were intramuscularly immunized with pVAX-ROP38 and those injected with pVAX I, PBS or nothing were treated as controls. After three injections at two week intervals, all mouse groups were challenged intraperitoneally with 1000 tachyzoites of the virulent T. gondii RH strain (Type I, ToxoDB #10) and 10 cysts of the PRU strain (Type II, ToxoDB #1), respectively. Results Mice inoculated with pVAX-ROP38 vaccine had a higher level of IgG antibodies (P
- Published
- 2014